Reports Q3 revenue $94.7M, consensus $89.39M. Net sales for the three months ended September 26, 2025, included $25.9 million related to the previously disclosed December China Shipment, which was paid in full during the third quarter of 2025. The year over year increase in net sales was primarily driven by the December China Shipment combined with 7.7% growth in net sales outside China, partially offset by lower new orders from distributors in China during the third quarter of 2025, due in part to leaner inventory management during the quarter. Excluding China, net sales were $38.9 million, an increase of 7.7% as compared to $36.1 million in the prior year quarter.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA:
- Broadwood ‘condemns’ Alcon’s ‘fallacious’ attacks on Staar Surgical
- Staar Surgical asked Alcon to increase merger consideration
- Unusually active option classes on open October 29th
- Staar Surgical may be discussing amended deal terms, says Piper Sandler
- Staar Surgical rallies after postponing stockholder meeting on merger